GSK plc (GSK)

NYSE · Healthcare · Drug Manufacturers - General
$47.76-0.13%As of 2026-11-22 · USD
Last session low $47.70Last session high $48.72
52-week low $45.8352-week high $61.70
Market cap
$95.73B
Sector
Healthcare
P/E (TTM)
16.6x
Dividend yield
3.84%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)40.6In the neutral range (30 to 70)
MACD (12, 26, 9)-0.17Below its signal line (0.16); histogram -0.33
Bollinger %B (20, 2)3%Inside the bands (47.61 to 52.12)
SMA 2049.86Price is 4.2% below
SMA 5049.31Price is 3.1% below
SMA 20052.06Price is 8.3% below
ATR (20)2.37% of priceAverage true range per day
52-week position12%In the lower part of the 45.83 to 61.70 range

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments.

Insider filings, 90 days18 purchases (about $427K) and no sales.
Latest fiscal yearEnded 2025-12-31: revenue of 32.67B GBP and an operating margin of 25.5%.

Also listed as GSK.L (LSE)

More in Drug Manufacturers - General